Liang Li1, John W Holloway2, Susan Ewart3, Syed Hasan Arshad4,5, Caroline L Relton6, Wilfried Karmaus1, Hongmei Zhang1. 1. Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, University of Memphis, Memphis, Tennessee, USA. 2. Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK. 3. College of Veterinary Medicine, Michigan State University, East Lansing, Michigan, USA. 4. Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK. 5. The David Hide Asthma and Allergy Research Centre, St Mary's, Hospital, Newport, UK. 6. MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Abstract
BACKGROUND: Little is known about the association of newborn DNA methylation (DNAm) with asthma acquisition across adolescence and early adult life. OBJECTIVE: We aim to identify epigenetic biomarkers in newborns for asthma acquisition during adolescence or young adulthood. METHODS: The Isle of Wight Birth Cohort (IOWBC) (n = 1456) data at ages 10, 18 and 26 years were assessed. To screen cytosine-phosphate-guanine site (CpGs) potentially associated with asthma acquisition, at the genome scale, we examined differentially methylated regions (DMR) using dmrff R package and individual CpG sites using linear regression on such associations. For CpGs that passed screening, we examined their enrichment in biological pathways using their mapping genes and tested their associations with asthma acquisitions using logistic regressions. Findings in IOWBC were tested in an independent cohort, the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort. RESULTS: In total, 2636 unique CpGs passed screening, based on which we identified one biological pathway linked to asthma acquisition during adolescence in females (FDR adjusted p-value = .003 in IOWBC). Via logistic regressions, for females, four CpGs were shown to be associated with asthma acquisition during adolescence, and another four CpGs with asthma acquisition in young adulthood (FDR adjusted p-value < .05 in IOWBC) and these eight CpGs were replicated in ALSPAC (all p-values < .05). DNAm at all the identified CpGs was shown to be temporally consistent, and at six of the CpGs was associated with expressions of adjacent or mapping genes in females (all p-values < .05). For males, 622 CpGs were identified in IOWBC (FDR = 0.01), but these were not tested in ALSPAC due to small sample sizes. CONCLUSION AND CLINICAL RELEVANCE: Eight CpGs on LHX5, IL22RA2, SOX11, CBX4, ACPT, CFAP46, MUC4, and ATP1B2 genes have the potential to serve as candidate epigenetic biomarkers in newborns for asthma acquisition in females during adolescence or young adulthood.
BACKGROUND: Little is known about the association of newborn DNA methylation (DNAm) with asthma acquisition across adolescence and early adult life. OBJECTIVE: We aim to identify epigenetic biomarkers in newborns for asthma acquisition during adolescence or young adulthood. METHODS: The Isle of Wight Birth Cohort (IOWBC) (n = 1456) data at ages 10, 18 and 26 years were assessed. To screen cytosine-phosphate-guanine site (CpGs) potentially associated with asthma acquisition, at the genome scale, we examined differentially methylated regions (DMR) using dmrff R package and individual CpG sites using linear regression on such associations. For CpGs that passed screening, we examined their enrichment in biological pathways using their mapping genes and tested their associations with asthma acquisitions using logistic regressions. Findings in IOWBC were tested in an independent cohort, the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort. RESULTS: In total, 2636 unique CpGs passed screening, based on which we identified one biological pathway linked to asthma acquisition during adolescence in females (FDR adjusted p-value = .003 in IOWBC). Via logistic regressions, for females, four CpGs were shown to be associated with asthma acquisition during adolescence, and another four CpGs with asthma acquisition in young adulthood (FDR adjusted p-value < .05 in IOWBC) and these eight CpGs were replicated in ALSPAC (all p-values < .05). DNAm at all the identified CpGs was shown to be temporally consistent, and at six of the CpGs was associated with expressions of adjacent or mapping genes in females (all p-values < .05). For males, 622 CpGs were identified in IOWBC (FDR = 0.01), but these were not tested in ALSPAC due to small sample sizes. CONCLUSION AND CLINICAL RELEVANCE: Eight CpGs on LHX5, IL22RA2, SOX11, CBX4, ACPT, CFAP46, MUC4, and ATP1B2 genes have the potential to serve as candidate epigenetic biomarkers in newborns for asthma acquisition in females during adolescence or young adulthood.
Authors: Nienke M Vink; Dirkje S Postma; Jan P Schouten; Judith G M Rosmalen; H Marike Boezen Journal: J Allergy Clin Immunol Date: 2010-09 Impact factor: 10.793
Authors: Avery DeVries; Gabriela Wlasiuk; Susan J Miller; Anthony Bosco; Debra A Stern; I Carla Lohman; Janet Rothers; Anya C Jones; Jessie Nicodemus-Johnson; Monica M Vasquez; John A Curtin; Angela Simpson; Adnan Custovic; Daniel J Jackson; James E Gern; Robert F Lemanske; Stefano Guerra; Anne L Wright; Carole Ober; Marilyn Halonen; Donata Vercelli Journal: J Allergy Clin Immunol Date: 2016-12-21 Impact factor: 10.793
Authors: Hans Bisgaard; Mette Northman Hermansen; Frederik Buchvald; Lotte Loland; Liselotte Brydensholt Halkjaer; Klaus Bønnelykke; Martin Brasholt; Andreas Heltberg; Nadja Hawwa Vissing; Sannie Vester Thorsen; Malene Stage; Christian Bressen Pipper Journal: N Engl J Med Date: 2007-10-11 Impact factor: 91.245
Authors: Sarah E Reese; Cheng-Jian Xu; Herman T den Dekker; Mi Kyeong Lee; Sinjini Sikdar; Carlos Ruiz-Arenas; Simon K Merid; Faisal I Rezwan; Christian M Page; Vilhelmina Ullemar; Phillip E Melton; Sam S Oh; Ivana V Yang; Kimberley Burrows; Cilla Söderhäll; Dereje D Jima; Lu Gao; Ryan Arathimos; Leanne K Küpers; Matthias Wielscher; Peter Rzehak; Jari Lahti; Catherine Laprise; Anne-Marie Madore; James Ward; Brian D Bennett; Tianyuan Wang; Douglas A Bell; Judith M Vonk; Siri E Håberg; Shanshan Zhao; Robert Karlsson; Elysia Hollams; Donglei Hu; Adam J Richards; Anna Bergström; Gemma C Sharp; Janine F Felix; Mariona Bustamante; Olena Gruzieva; Rachel L Maguire; Frank Gilliland; Nour Baïz; Ellen A Nohr; Eva Corpeleijn; Sylvain Sebert; Wilfried Karmaus; Veit Grote; Eero Kajantie; Maria C Magnus; Anne K Örtqvist; Celeste Eng; Andrew H Liu; Inger Kull; Vincent W V Jaddoe; Jordi Sunyer; Juha Kere; Cathrine Hoyo; Isabella Annesi-Maesano; Syed Hasan Arshad; Berthold Koletzko; Bert Brunekreef; Elisabeth B Binder; Katri Räikkönen; Eva Reischl; John W Holloway; Marjo-Riitta Jarvelin; Harold Snieder; Nabila Kazmi; Carrie V Breton; Susan K Murphy; Göran Pershagen; Josep Maria Anto; Caroline L Relton; David A Schwartz; Esteban G Burchard; Rae-Chi Huang; Wenche Nystad; Catarina Almqvist; A John Henderson; Erik Melén; Liesbeth Duijts; Gerard H Koppelman; Stephanie J London Journal: J Allergy Clin Immunol Date: 2018-12-21 Impact factor: 10.793
Authors: Abigail Fraser; Corrie Macdonald-Wallis; Kate Tilling; Andy Boyd; Jean Golding; George Davey Smith; John Henderson; John Macleod; Lynn Molloy; Andy Ness; Susan Ring; Scott M Nelson; Debbie A Lawlor Journal: Int J Epidemiol Date: 2012-04-16 Impact factor: 7.196
Authors: Rutu Patel; Farnaz Solatikia; Hongmei Zhang; Alemayehu Wolde; Latha Kadalayil; Wilfried Karmaus; Susan Ewart; Ryan Arathimos; Caroline Relton; Susan Ring; Alexander John Henderson; Syed Hasan Arshad; John W Holloway Journal: Clin Exp Allergy Date: 2020-11-25 Impact factor: 5.401